Peking University People's Hospital and Peking University Institute of Hematology, Beijing, People's Republic of China.
Biol Blood Marrow Transplant. 2011 Oct;17(10):1436-42. doi: 10.1016/j.bbmt.2011.05.020. Epub 2011 Jun 12.
Partially HLA-mismatched related, or HLA-haploidentical, donor stem cell transplantation (SCT) is a feasible therapeutic option for advanced hematologic malignancy patients who lack an HLA-matched related or unrelated donor. Natural killer (NK) cells, a major cell type of the innate immune system, express surface receptors that regulate potent effector functions, such as cytolytic activity and the release of cytokines, and play a central role in the inflammatory response and immunoregulation. Conflicting results have been reported regarding the impact of NK cell alloreactivity on the outcome of haploidentical SCT in leukemic patients. This review summarizes the heterogeneous clinical results and explains the underlying mechanisms with respect to the reconstitution kinetics of NK cells and the interactions between NK cells and T cells.
部分 HLA 不匹配相关或 HLA 单倍体相合供者干细胞移植(SCT)是一种可行的治疗选择,适用于缺乏 HLA 匹配相关或无关供者的晚期血液恶性肿瘤患者。自然杀伤(NK)细胞是先天免疫系统的主要细胞类型,表达调节有效效应功能的表面受体,如细胞溶解活性和细胞因子的释放,并在炎症反应和免疫调节中发挥核心作用。关于 NK 细胞同种反应性对白血病患者单倍体相合 SCT 结局的影响,已有相互矛盾的结果报道。这篇综述总结了不同的临床结果,并解释了 NK 细胞重建动力学和 NK 细胞与 T 细胞之间相互作用方面的潜在机制。